Yu‐Ju Wei
Impact in
- Hepatology top 10%
- Hepatitis C virus research
- Liver Disease and Transplantation
-
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
- Cervical Cancer and HPV Research
Papers in
- Epidemiology 23
- Liver Disease Diagnosis and Treatment 21
- Hepatitis B Virus Studies 14
- Hepatology 18
- Hepatitis C virus research 14
- Liver Disease and Transplantation 6
- Liver Diseases and Immunity 2
- Hepatocellular Carcinoma Treatment and Prognosis 1
- Co-authors
- Ming‐Lung Yu (23 shared papers)Chia‐Yen Dai (22 shared papers)Chung‐Feng Huang (22 shared papers)Po‐Cheng Liang (20 shared papers)Wan‐Long Chuang (21 shared papers)Ming‐Yen Hsieh (14 shared papers)Ming‐Lun Yeh (20 shared papers)Jee‐Fu Huang (21 shared papers)
- Journals
- Journal of Gastroenterology and Hepatology (3 papers)Alimentary Pharmacology & Therapeutics (2 papers)PLoS ONE (2 papers)Liver International (1 paper)Clinical & Translational Oncology (1 paper)
- Partner nations
- TaiwanSwitzerlandChina
In The Last Decade
Yu‐Ju Wei
23 papers receiving 135 citations
Peers
Comparison fields: 5 of 47
- Hepatology 65
- Epidemiology 79
- Geriatrics and Gerontology 6
- Cancer Research 18
- Immunology and Allergy 5
Countries citing papers authored by Yu‐Ju Wei
This map shows the geographic impact of Yu‐Ju Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ju Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ju Wei more than expected).
Fields of papers citing papers by Yu‐Ju Wei
This network shows the impact of papers produced by Yu‐Ju Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ju Wei. The network helps show where Yu‐Ju Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu‐Ju Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 14 | |
| 2 | 2015 | 13 | |
| 3 | 2020 | 12 | |
| 4 | 2016 | 12 | |
| 5 | 2022 | 12 | |
| 6 | 2019 | 11 | |
| 7 | 2023 | 10 | |
| 8 | 2021 | 7 | |
| 9 | 2021 | 7 | |
| 10 | 2021 | 6 | |
| 11 | 2024 | 4 | |
| 12 | 2023 | 4 | |
| 13 | 2022 | 4 | |
| 14 | 2024 | 4 | |
| 15 | 2022 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2023 | 2 | |
| 18 | 2024 | 2 | |
| 19 | 2022 | 2 | |
| 20 | Serum Osteopontin Levels Correlate with Clinical and Pathological Features in Non-Small Cell Lung Cancer. | 2015 | 2 |
About Yu‐Ju Wei
Yu‐Ju Wei is a scholar working on Epidemiology, Hepatology, Molecular Biology, Cancer Research and General Health Professions, having authored 28 papers that have together received 139 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (21 papers), Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (14 papers), Liver Disease and Transplantation (6 papers), Liver Diseases and Immunity (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer-related gene regulation (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Hepatology (65 citations), Epidemiology (79 citations), Geriatrics and Gerontology (6 citations), Cancer Research (18 citations) and Immunology and Allergy (5 citations). Yu‐Ju Wei has collaborated with scholars based in Taiwan, Switzerland and China. Frequent co-authors include Ming‐Lung Yu, Chia‐Yen Dai, Chung‐Feng Huang, Po‐Cheng Liang, Wan‐Long Chuang, Ming‐Yen Hsieh, Ming‐Lun Yeh, Jee‐Fu Huang, Yi‐Hung Lin and Ching‐I Huang. Their work appears in journals such as Journal of Gastroenterology and Hepatology, Alimentary Pharmacology & Therapeutics, PLoS ONE, Liver International and Clinical & Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.